v3.26.1
Stock-based Compensation (Tables)
3 Months Ended
Mar. 31, 2026
Share-Based Payment Arrangement [Abstract]  
Schedule of Summary of Stock Option Activity

The following is a summary of the Company’s stock options activity (as adjusted for the Exchange Ratio) during the three months ended March 31, 2026 (1)

 

   Number of
Options
   Weighted
average
exercise price
(USD)
   Weighted
average
remaining
contractual
term
(years)
   Aggregate
intrinsic
value
(USD)
 
Balance as of December 31, 2025 (1)   49,486,556   $1.19    6.65   $290,074 
Granted (1)   
    
           
Exercised (1)   1,920,273    0.65           
Expired and forfeited (1)   328,667    1.52           
Balance as of March 31, 2026 (2)   47,237,616   $1.21    6.45   $304,683 
Exercisable as of March 31, 2026   31,038,814   $0.09    7.57   $234,840 
Unvested as of March 31, 2026   16,198,802   $3.02    4.64   $75,162 

 

(1)Recast to reflect the Exchange Ratio established in the Reverse Recapitalization.

 

(2)Shares have been recast to reflect the Exchange Ratio established in the Reverse Recapitalization.
Schedule of Stock-based Compensation Expense

The following table summarizes the stock-based compensation expense classified in the consolidated statements of operations and comprehensive loss for the three months ended March 31, 2026 and 2025:

 

   Three months ended
March 31,
 
   2026   2025 
Cost of revenue  $22   $10 
Research and development   1,013    643 
General and administrative   351    140 
Sales and marketing   22    18 
Total stock-based compensation expense  $1,408   $811